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Lymphatic Filariasis (LF) is targeted for elimination by the Global Programme for the Elimination of Lymphatic
Filariasis (GPELF). The strategy adopted is based on the density dependent phenomenon of Facilitation, which
hypothesizes that in an area where the vector species transmitting Wuchereria bancrofti are Anopheles mosquitoes,
it is feasible to eliminate LF using Mass Drug Administration (MDA) because of the inability of Anopheles species to
transmit low-density microfilaraemia. Even though earlier studies have shown Anopheles species can exhibit the
process of Facilitation in West Africa, observations point towards the process of Limitation in certain areas, in which
case vector control is recommended. Studies on Anopheles species in West Africa have also shown genetic
differentiation, cryptic taxa and speciation, insecticide resistance and the existence of molecular and chromosomal
forms, all of which could influence the vectorial capacity of the mosquitoes and ultimately the elimination goal.
This paper outlines the uniqueness of LF vectors in West Africa and the challenges it poses to the 2020 elimination
goal, based on the current MDA strategies.
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Introduction
The January 2012 London declaration on neglected tro-
pical diseases (NTDs) [1] instilled renewed confidence in
the global efforts to control or eliminate several NTDs,
including lymphatic filariasis (LF). LF, is caused by the
filarial parasites Wuchereria bancrofti, Brugia malayi or
Brugia timori and is presently endemic in 72 countries
[2]. Mosquito species belonging to the Anopheles, Culex,
Aedes, Mansonia, Coquillettidia and Ochlerotatus genera
are carriers of the LF parasites. In West Africa, Anopheles
mosquitoes (vectors of malaria) are the main vectors of LF
[3,4]. Although Culex mosquitoes have been suggested as
vectors of LF [5,6], the data was insufficient to confirm
that assertion. As such, there is minimal evidence that* Correspondence: dboakye@noguchi.mimcom.org
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reproduction in any medium, provided the orCulex mosquitoes contribute to the transmission of the
disease. Current practices in the management of LF have
been influenced by the push for integrated control of
NTDs amenable to mass drug administration (MDA) [7]
and the impact of vector control on LF transmission [8].
MDA coverage for LF increased from three million people
treated in 12 countries in 2000, to more than 450 million
in 53 countries in 2010 [9]. During that period, the disease
was eliminated in China and Korea. Nine countries no
longer require MDA [10] because of a natural decline in
transmission intensity attributed to a range/ or multiple
factors including vector control, provision of safe water,
sanitation and hygiene. Vector control is now among the
five strategies recommended by the WHO for prevention,
control, elimination and eradication of NTDs in its 2012
road map for implementation [11]. Prior to 2012, the
WHO strategy for LF elimination was based primarily on
chemotherapy. However, the impact of vector control on
LF transmission is becoming increasingly recognisedal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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LF transmission and the implications for accelerated
interruption of transmission in West Africa where the LF
vectors are also targeted through malaria control efforts is
important.
LF control based on density dependent processes in the
vectors
The Global Programme for the Elimination of Lymphatic
Filariasis (GPELF) strategy is based on the mass drug
administration (MDA) with Albendazole and either
DEC or Ivermectin to reduce circulating microfilariae
(mfs) below a threshold level, to break transmission by
the disease vectors. The rationale supporting this strat-
egy is based on results of research on vector-parasite
systems that determine whether vectors will be effective
in picking up and transmitting infection at low microfi-
laraemia levels [15]. These vector-parasite combinations
are described under the density-dependent processes of
“Facilitation” and “Limitation” [16]. Facilitation is the
process where, below a certain threshold level of mfs,
designated as Webber’s Critical Point [17], the trans-
mission by anopheline vectors will be interrupted
[18-20]. Limitation on the other hand represents a
process whereby even at low mf levels there is stable
transmission, which is found among culicines [4,21].
There is, however, a third case of non-regulated transmis-
sion by vectors, termed “Proportionality”. In this case,
there is a constant percentage (linear relationship) of mf
ingested by the vector during a blood meal developing to
the infective stage. Limitation and Facilitation in vectors
cause deviations from this linear relationship [21].
Limitation processes are linked with the fact that the
number of parasites per mosquito cannot increase indef-
initely. The relationship between mf intake and L3 out-
put is linear at the onset and approaches a constant
value or might decrease with increasing mf intake, as a
result of excess mortality of vectors caused by ingestion
of too many mf [21,22]. Thus in Limitation, there is a
maximum threshold below which the limited process is
‘overefficient’ and above which it is ‘under-efficient’ [21].
This relationship has been observed in the culicines
[4,18] which are believed not to be vectors of LF in West
Africa, with the possible exception of Mansonia sp., re-
cently reported to harbor infective mf in Ghana [23].
Thus in Limitation, the eradicability of LF is greatly
impaired by shifting transmission thresholds towards
lower values, requiring higher control efforts.
Facilitation processes on the other hand have been
observed in anopheline mosquitoes [18,19], which are
the vectors of LF in West Africa. Blood containing mf
moves through the proboscis by a pumping action cre-
ated by the cibarial and pharyngeal pumps. In some
mosquito species, the pumps are lined with denticulatestructures (cibarial armature) that can fatally damage
passing mf [24]. At low mf densities, this cibarial arma-
ture substantially reduces the proportion of surviving
mf. However, at high mf densities, the cibarial armature
becomes inefficient because it is masked by a few mf
promoting the survival of the others. Thus, at high mf
densities transmission becomes efficient by shifting
transmission thresholds towards higher values, which
can more easily be achieved by control measures [21].
The assumption that it will be easy to use MDA alone
in areas where W. bancrofti is transmitted by Anopheles
species, including most endemic areas in Africa, was
supported by results in Papua New Guinea (PNG),
which showed that transmission by An. punctulatus was
virtually eliminated after one year of treatment, even
though the frequency of carriers in the human popula-
tion ranged from 10.5% - 52.7% [25]. Also, one of the
earliest documented cases of the elimination of LF oc-
curred when indoor residual spraying with DDT to
control malaria inadvertently eradicated LF in the
Solomon Islands; here also the vector was an anopheline,
An. farauti [17,21]. In contrast, in the Polynesian Islands
of Moorea and Maupiti, where the vector was Aedes
polynesiensis, over 50 years of MDA using DEC did not
eliminate LF [17]. Despite these evidences and the as-
sumption of vector-parasite phenomenon of Facilitation
in Anopheles, there is current growing evidence that in
certain areas, Anopheles species may be exhibiting the
process of Limitation [26,27].
Diversity of An. gambiae vectors of LF in West Africa
There is diversity among the vectors of LF, and there-
fore, it may not be practical to generalize based on data
from PNG and the Solomon Islands. Threshold levels of
microfilaraemia needed for the elimination of anopheline
transmitted W. bancrofti LF might differ from species to
species. The major Anopheles vectors of LF in West
Africa are An. gambiae s.l, and the An. funestus group
[26]. These species complexes are made up of distinct
species, which are morphologically indistinguishable and
may occur in sympatric situations. For example, in
Ghana, several sympatric Anopheles species are vectors
[26,28,29], and these are likely to differ in their vectorial
role and in their capacity to transmit low-density micro-
filaraemia. Results of earlier studies in sub-Saharan
Africa on the quantitative relations of transmission in-
tensity and microfilarial reservoir have been found to
vary among members of the An. gambiae complex and
An. funestus [30-32]. These variations may include the
proportion of mfs ingested by Anopheles mosquitoes
which are damaged by their cibarial teeth, the percen-
tage of mosquitoes ingesting mf and host mf density and
the percentage of mosquitoes infected or mf density per
mosquito and numbers of mf per ml of host blood. In
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cance of these processes, Southgate and Bryan reported
the presence of Facilitation in An. gambiae/W. bancrofti
from The Gambia, Burkina Faso and Tanzania [19]. In
the same paper, although Facilitation was indicated for
An. arabiensis/W. bancrofti when data from The Gambia
and Tanzania were combined, the results from Tanzania
alone did not indicate Facilitation. This difference in
results was attributed to the low numbers of mosquitoes
studied. Similarly, the observed non-facilitation for
An. melas, An. merus and An. funestus was also attribu-
ted to low numbers of mosquitoes examined. However,
it is possible that the non-Facilitation observed for these
Anopheles/W. bancrofti combinations could have been
due to variation in transmission efficiency inherent in
the vectors and not necessarily to the low numbers of
mosquitoes dissected. Webber commented on the possi-
bility of eradicating anopheline-transmitted filariasis but
did not discuss the information on An. melas, An. merus
and An. funestus as vectors in Africa [20]. Recent studies
by Amuzu and colleagues (2010), aimed at examining
the cibarial armature of An. gambiae M and S molecular
forms and An. melas in an area endemic for LF in
Ghana, showed significantly less number of cibarial teeth
in the An. melas compared to the M and S forms of the
An. gambiae s.s [27]. As such, it is very clear from the
above that anopheline LF vectors in West Africa may
differ in their capacity to sustain low-level microfilarae-
mia. Furthermore, in areas of Ghana where MDA has
not been able to eliminate transmission after more than
7 years of intervention, the main vector is An. melas
(Boakye unpublished reports to WHO).
The diversity in Anopheles vectors of LF in West
Africa is well documented from studies of malaria vec-
tors in this region. Five chromosomal forms namely;
“Forest”, “Bissau”, “Bamako”, “Mopti” and “Savannah”
have been described [33-35]. The Mopti form of
An. gambiae s.s, for example, is believed to be more
associated with W. bancrofti [36], and is a relatively poor
vector of malaria compared with other species such as
the Savannah form [37,38]. There is further evidence
suggesting that cryptic taxa may exist within An. gam-
biae s.s due to observed inversions in the micromor-
phology of the second chromosome for different
populations [39] and thus selective effects due to the
increase in certain inversion arrangements may result
[33-35]. To add to these, incipient speciation has been
reported among members of the Anopheles species in
West Africa [40,41], raising further questions as to why
these are only reported in West Africa and not else-
where on the continent [42,43].
Two widespread molecular types, termed M and S
forms [40,44] have also been described among the
Anopheles gambiae s.s. Recent evidence also suggeststhe existence of two distinct chromosomal forms within
the M form [45]. In Mali and Burkina Faso, the M form
corresponds to the Mopti chromosomal form, whereas
sympatric populations of Savannah and Bamako belong
to the S molecular form. However, the correspondence
between chromosomal and molecular forms does not
hold true elsewhere in West Africa, especially where the
Forest chromosomal forms exist [40,46].
Insecticide resistance has also been reported among
the various vectors of LF on the African continent. The
pyrethroid resistance mechanism of kdr mutation had
been found distributed in the M and S forms of
An. gambiae s.s., [47-49]. DDT and pyrethroid resistance
have been widely observed in Africa, in An. gambiae s.s.
and An. arabiensis, with multiple-resistance mechanisms
observed in West Africa [50-53]. These resistance
mechanisms may inadvertently influence the density
dependent processes and the vector competence of
various Anopheles species. Studies have suggested
that highly elevated esterases involved in insecticide-
resistance may inhibit development of mf in Culex [54],
and similar effects could occur in insecticide resistant
Anopheles [55,56].
The variability in diversity of Anopheles vectors of LF
in West Africa may also be influenced by climate effects,
such as temperature and rainfall, which indirectly may
influence the transmission of LF [56,57]. In a study to
assess the environmental factors affecting the distribu-
tion of An. gambiae s.s. in Ghana and the effects on dis-
ease distribution, de Souza and colleagues noted that
temperature was the key factor affecting the distribution
of the M and S forms of the An. gambiae s.s and that
the M was significantly correlated with LF, and more
prevalent in the high LF areas compared to low LF
areas [58]. West Africa is the only region with the high-
est number of ecological zones (Mangrove, Coastal
Savannah, Guinea Savannah, Sudan Savannah, Sahel
Savannah, Semi-deciduous Forest and Evergreen Forest)
in the world, the impact of these ecologies on vector
diversity and disease transmission dynamics should
not be overlooked. As such, the climate impacts on the
biology of disease vectors will greatly affect their impor-
tance. Thus, an understanding of biodiversity and the
importance of vector ecology crucial for the successful
control of vector diseases [56,57].
Eradicability of lymphatic filariasis in West Africa
A single strategy of MDA has been advocated for the elim-
ination of LF in Africa, notwithstanding the diversity in
the vectors of the disease. Some evidence [59,60] suggests
the need for vector control as a supplement to MDA, in
some areas, to achieve the elimination target of GPELF.
For this, an appropriate vector control strategy to comple-
ment MDA in Africa will have to take a cue from previous
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combating malaria has been attributed to mosquito con-
trol; yet, in recent times, this strategy has largely failed
due to various reasons, including the development of in-
secticide resistance [63], economic Limitations and gaps
in the basic biological knowledge of these vectors [64].
Vector control is an important component of the con-
trol of vector-borne diseases. Early efforts, before the era
of DDT to control pests and disease vectors, took an
ecological approach in the form of physical modification
of the environment, chemical control and personal pro-
tection [65]. After the introduction of DDT and the syn-
thetic insecticides, this approach lost its prominence and
vector control became synonymous with insecticide use.
The use of DDT and its analogs was heralded as the
solution for the control of all insect pests, including vec-
tors of human infection. This led to improper insecticide
use, which had an enormous negative impact on non-
target organisms causing a loss of biodiversity. Although
most of the negative impacts resulted from insecticide
application to control agricultural pests, vector control
suffered as a consequence. This situation coupled with
the development of vector resistance to most insecti-
cides, and the high cost of new insecticides and their
application led to a loss of interest in vector control and
put emphasis on chemotherapy [66].
The GPELF is based on a strategy of MDA with
Albendazole and DEC or Ivermectin, with the aim of re-
ducing the parasite load in the human host, thereby pre-
venting transmission, and a target of 80% coverage of
the population at risk for at least 5 years [15] has been
proposed. This ideal is not always achievable because of
programmatic issues of drug distribution [67] and the
perpetual threat of drug resistance [68,69]. Even if this
level of coverage is achieved, the diversity of vectors and
their differing abilities to transmit low level parasitaemia,
may lead to a failure to stop transmission in some
regions, after the interruption of MDA. In view of the
above, vector control is now considered an important
and integral part necessary to achieve elimination in spe-
cific areas where MDA alone will not provide the solu-
tion. This is especially important, with the very recent
report of Mansonia spp. being very efficient vectors of
LF, in Ghanaian communities [23], where they were pre-
viously thought to be non-vector species.
Furthermore, studies have suggested differing LF
transmission efficiencies for the M and S molecular
forms of the An. gambiae s.s [27,36], with the M form
being a more efficient vector. Similar observations have
been made with An. melas (Boakye et al., Unpublished),
where An. melas is a more efficient vector than the
An. gambiae s.s. Based on these findings we propose a
model for the interruption of LF transmission in these
different vector areas. Thus, areas with the predominantS form may require fewer MDA treatments. With the M
form and An. melas exhibiting possible Limitation [24]
areas with the predominant M form and An. melas may
require longer treatment periods in addition to vector
control measures. The implication of this, should it be
tested and proven, will be in its economic importance.
As such, in areas where there are high proportions of
the An. gambiae S form, LF transmission may be inter-
rupted using 3 to 5 rounds of MDA alone. On the other
hand, LF transmission may require more than 5 rounds
of MDA, and be complemented with vector control
measures in areas with high numbers of An. gambiae M
form and An. melas. Areas with equal proportions of M
and S forms may also require additional vector control
measures. This model, however, needs to be tested and
evaluated in different vector areas. Countries like Guinea
and Liberia that are yet to start MDA may provide the
best settings for testing this model.
In the areas where vector control needs to be imple-
mented, an integrated vector management (IVM) strat-
egy targeted at the major vectors may needs to be
adhered to and coordinated with MDA to give the best
results at least cost [14]. LF fortunately shares the same
vectors with malaria in most African countries and the
practices for controlling the vectors of malarial parasites
(the use of insecticide treated bednets, indoor-residual
spraying) for personal and community protection - can
at the same time be effective against both malaria and
LF [70,71]. Even though the GPELF is based on MDA,
vector control activities of the 'Roll Back Malaria’ cam-
paign can considerably suppress the risk of W. bancrofti
transmission in co-endemic areas.
Conclusion
The use of current MDA alone campaigns, for LF elim-
ination, in West Africa is based on two assumptions; 1.
Anopheles species are the only vectors of LF in West
Africa and 2. Anopheles vectors of W. bancrofti exhibit
the vector-parasite process of Facilitation, based on
which elimination is feasible through MDA alone. How-
ever, the recognition of different LF vectors in West Af-
rica [23], with differing vector-parasite processes [26,27]
and differing transmission efficiencies [27,36], all repre-
sent significant challenges to the GPELF 2020 objectives
in the West African sub-region. Moreover, despite 5–8
rounds of MDA treatment, field reports have revealed
persistent residual LF infections in some communities in
Ghana and Burkina Faso [23]. Though reasons of non-
compliance could be attributed to these residual infec-
tions [72], others have also hypothesized the influence
by vector species [26,27]. It is also important to note
that these observations may not be the same for every
West African country, as factors such as ecology, species
composition/diversity and insecticide resistance may
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Thus, an understanding of the vector competence of
mosquitoes infected with W. bancrofti in different areas
would be of particular interest and could be addressed
using field or laboratory models. Nonetheless, despite
these challenges, LF control efforts in West Africa
should be supplemented with vector control, if the
GPELF elimination goals of 2020 are to be achieved in
West African countries.
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